(Q53208005)

English

A double-blind, placebo-controlled crossover study of ganglioside GM1 treatment for Alzheimer's disease.

scientific article published in January 1994

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8267111

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/8267111

title

A double-blind, placebo-controlled crossover study of ganglioside GM1 treatment for Alzheimer's disease. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8267111

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/8267111

1 reference

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8267111

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/8267111

author name string

Flicker C

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8267111

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/8267111

Kalkstein D

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8267111

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/8267111

Serby M

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8267111

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/8267111

language of work or name

English

0 references

publication date

1 January 1994

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8267111

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/8267111

published in

American Journal of Psychiatry

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8267111

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/8267111

volume

151

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8267111

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/8267111

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8267111

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/8267111

page(s)

126-129

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8267111

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/8267111

Identifiers

DOI

10.1176/AJP.151.1.126

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8267111

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/8267111

PubMed publication ID

8267111

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8267111

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/8267111

(Q53208005)

A double-blind, placebo-controlled crossover study of ganglioside GM1 treatment for Alzheimer's disease.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)